CHELSEA MACKEY: Open Payments
NPI 1780238782 · SPRINGDALE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,872 in 135 payments from 18 companies in 2025. Trend: 2023 $2,580 · 2024 $3,507 · 2025 $2,872
Food & beverage: $2,872
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 51 | $811 |
| Ipsen Biopharmaceuticals, Inc | 14 | $421 |
| Janssen Scientific Affairs, LLC | 2 | $264 |
| Madrigal Pharmaceuticals | 6 | $234 |
| Phathom Pharmaceuticals, Inc. | 11 | $200 |
| Janssen Biotech, Inc. | 11 | $199 |
| Gilead Sciences, Inc. | 9 | $175 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $172 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $90 |
| Regeneron Healthcare Solutions, Inc. | 3 | $81 |
Products named: TREMFYA, IQIRVO, RINVOQ, REZDIFFRA, VOQUEZNA, LINZESS, SKYRIZI, EOHILIA.
Industry payments across AR — which companies pay providers there.
